GET THE APP

Review on polycystic ovary syndrome, clinical manifestations, diagnostic

Journal of Genital System & Disorders.ISSN: 2325-9728

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Review on polycystic ovary syndrome, clinical manifestations, diagnostic

Polycystic ovarian syndrome emerges as the most conspicuous endocrinopathy affecting 2.2-20% of women belonging to re- productive age group. Diagnosis of PCOS is established when 2/3 of the Rotterdam’s criteria is met i.e., hyperandrogenism, ovulatory dysfunction and polycystic ovaries. (12 or more fol- licles of size 2-9 mm in each ovary and/or ovarian volume >10 ml). According to guidelines from endocrine society, early rec- ognition of PCOD facilitate healthcare providers to prevent and treat adequately wide range of metabolic complications i.e., impaired glucose tolerance, type-II diabetes mellitus, meta- bolic syndrome, dyslipidemia, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, obesity, obstructive sleep ap- nea and cardiovascular diseases. Diagnostic workup and man- agement of PCOS is based on correction of metabolic derange- ments, psychosocial problems, control of menstrual cycle and prevention of endometrial hyperplasia, assessment of ovula- tion/fertility and reduction of dermatological manifestations. Patient’s desire for induction of ovulation and pregnancy plays a pivotal role in management of PCOS. This study emphasizes on potentially risk factors and impacts of PCOS on multiple systems along with various treatment modalities (pharmaceu- tical therapy, hormonal contraceptives and lifestyle modifica- tion) available to nullify them. Self-care and multidisciplinary approach to reduce the morbidity due to PCOS.

Special Features

Full Text

View

Track Your Manuscript

Media Partners

Associations